Rentschler Biopharma SE appoints Alexander Dettmer as CFO

Alexander Dettmer, Chief Financial Officer, Rentschler Biopharma SE

Rentschler Biopharma SE, a global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, has appointed Alexander Dettmer as CFO, effective 1 July, 2020. Mr Dettmer brings 15 years of financial, business development and leadership experience with a focus on driving operational excellence in the healthcare and life sciences sectors. At Rentschler Biopharma, he will be heading the finance, supply chain management, information technology and legal functions. Mr Dettmer succeeds Stefan Rampf, who will be leaving the company, effective 30 June, 2020 to pursue a new opportunity.

Prof Dr Nikolaus F. Rentschler, Chairman of the Board of Rentschler Biopharma, said: “It is my great pleasure to announce the appointment of Alexander Dettmer as our new CFO. He is a highly respected professional with a demonstrated record of success, deeply rooted in his commitment to sustainable value creation. I am therefore convinced, that he is an ideal match for our management team at Rentschler Biopharma. I would also like to take the opportunity to thank Stefan Rampf for his exceptional support and the trust underlying our work. I wish him all the best with his new plans and all professional and personal endeavours.”

Prior to joining Rentschler Biopharma, Mr Dettmer successfully held several senior leadership positions within the Fresenius SE & Co. KGaA group, which he joined in 2005. His last role was Senior Vice President Corporate Business Development/M&A, where he led the broader M&A team that managed M&A transaction processes. Previous to that, he was CFO of Fresenius Kabi’s Medical Devices Division, Executive VP Finance, Procurement & HR, where his responsibilities included financial planning, controlling, compliance, strategic purchasing and product partnering. Before that, he was CFO and Managing Director at Fresenius Biotech GmbH (now: Neovii Biotech). Mr Dettmer studied in Boston, MA, USA as well as in Singapore and holds a Diploma in Economics and Business Administration (Lic. Oec.) from the University of St. Gallen (HSG), Switzerland.

Featured Companies

Rentschler Biopharma SE (more information, website)